Chureen Carter, PharmD, MS

This retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.

This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.